In a time where almost no niche area is left unexplored, life science organizations need to assess the competitive landscape for a therapeutic area and prioritize their R&D spend accordingly. Informed decision-making is pivotal to the successful development and commercialization of a new drug, and companies need to have a streamlined process for gaining strategic input from multiple functional teams along a product’s development cycle to help navigate the competitive landscape.

The 4th New Product Planning Summit serves as an educational platform for new product development, commercial planning, brand strategy, and marketing professionals to discuss how to utilize tools and resources to optimize early decision-making, collaborate with cross-functional partners to guide product development, and leverage key insights to tailor a product plan to ensure the successful launch of a new product.

Top Five Reasons to Attend:

1. Learn about perspectives and best practices for new product planning from across different therapeutic areas, geographies and healthcare segments
2. Examine portfolio optimization and prioritization metrics that demonstrate the value of pipeline planning and support business cases for new products
3. Develop a global marketing communication and a launch strategy that is impactful and tailored to the needs of regional affiliates
4. Explore the use of real-world evidence to enhance the value proposition of new products
5. Examine how new product planning functions are structured, governed and operated at various companies and the key challenges they face

Who Should Attend

This conference is designed for representatives from pharmaceutical, biotechnology, and medical device companies with responsibilities in the following areas: